Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:286480.
doi: 10.1155/2012/286480. Epub 2012 Dec 13.

Treatment of Basal cell carcinomas with pulsed dye laser: a case series

Norman Minars  1 , Marianna Blyumin-Karasik
Affiliations

Treatment of Basal cell carcinomas with pulsed dye laser: a case series

Norman Minars et al. J Skin Cancer. 2012.

Abstract

Background. Basal cell carcinoma (BCC) is the most prevalent skin cancer. Because of its highly vascular characteristic, it is amendable to treatment with pulse dye laser (PDL). The goal of this study is to determine the safety and efficacy of PDL therapy for mostly facial BCCs. Materials and Methods. Sixteen men and thirteen women (29 total) with 39 biopsy-proven BCCs were treated with 1-4 PDL (595 nm) therapies at 2-4-week intervals. The treatment parameters included pulse energy of 15 J/cm 2, pulse length of 3 millisecond, with no dynamic cooling, and 7 mm spot size. The age of the patients was 30-90 years (mean 73 years). Response rates were evaluated by the clinical assessments with mean followup of 11 months. Results. Twenty-four patients with thirty-two tumors reached at least three months followup: 24/32 (75%) tumors with complete resolution (mean 3 treatment sessions); 5/32 (16%) tumors recurred; 3/32 (9%) tumors with incomplete responses after four treatments. Minimal side effects and discomfort were experienced by the patients with PDL therapy. Conclusion. PDL is a safe, tolerable, and moderately effective method of treating various BCCs. The ideal niche and standardized settings for PDL treatment of BCCs are yet to be determined.

PubMed Disclaimer

Figures

Figure 1
Figure 1
BCCs on the upper mid lip before PDL treatment.
Figure 2
Figure 2
BCCs on the upper mid lip immediately after PDL treatment.
Figure 3
Figure 3
BCC in the right upper lip, before and three months after PDL treatment. Complete resolution of the lesion.
Figure 4
Figure 4
BCC on the left cheek, before and three months after PDL treatment. Complete resolution of the lesion.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Arora A, Attwood J. Common skin cancers and their precursors. Surgical Clinics of North America. 2009;89(3):703–712. - PubMed
    1. Tierney EP, Hanke CW. Cost effectiveness of Mohs micrographic surgery: review of the literature. Journal of Drugs in Dermatology. 2009;8(10):914–922. - PubMed
    1. Lien MH, Sondak VK. Nonsurgical treatment options for Basal cell carcinoma. Journal of Skin Cancer. 2011;2011:6 pages.571734 - PMC - PubMed
    1. Shah SM, Konnikov N, Duncan LM, Tannous ZS. The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas. Lasers in Surgery and Medicine. 2009;41(6):417–422. - PubMed
    1. Campolmi P, Troiano M, Bonan P, Cannarozzo G, Lotti T. Vascular based non conventional dye laser treatment for basal cell carcinoma. Dermatologic Therapy. 2008;21(5):402–405. - PubMed

LinkOut - more resources